With a market cap of $681.8 billion, Eli Lilly and Company (LLY) is a leading global pharmaceutical company focused on neuroscience, diabetes, oncology, and immunology. The company markets a broad ...

Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced that Swiss Urban autonomy ...

Aeva Technologies, Inc. (NASDAQ:AEVA), which has seen its stock surge nearly 390% over the past year according to InvestingPro data, has announced a collaboration with Swiss company Loxo ...

--(BUSINESS WIRE)--Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced that Swiss Urban autonomy software provider Loxo has selected its long-range ...

Aeva’s Atlas 4D LiDAR Sensors Enable Reliable Autonomy Across Loxo’s Vehicle Fleet Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced that Swiss ...

Aeva ® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced that Swiss Urban autonomy software provider Loxo has selected its long-range 4D LiDAR technology ...

The Swiss start-up LOXO promises to solve all these problems with its autonomous vehicle for last mile delivery. "Thanks to electric propulsion, optimal charging capacity and the autonomous ...

BERN, Switzerland, Dec. 7, 2022 /PRNewswire/ -- Tech start-up LOXO today unveiled its autonomous vehicle for last mile delivery. Developed and produced in Switzerland, it will be on public roads ...

About three years after pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) acquired Loxo Oncology Inc. in a deal worth about $8 billion, the merged companies stepped into the spotlight Thursday with ...

Besides Retevmo, Loxo’s BTK inhibitor LOXO-305 belongs to Lilly. At the 2019 American Society of Hematology annual meeting, it reported positive preliminary results from a phase 1/2 trial in ...

Indianapolis-based Eli Lilly & Co. said it would create a new organization within the company, Loxo Oncology at Lilly. Lilly acquired Stamford, Connecticut-based Loxo Oncology in January for $8 ...